Edition:
India

Livzon Pharmaceutical Group Inc (1513.HK)

1513.HK on Hong Kong Stock

66.10HKD
9:16am IST
Change (% chg)

HK$-0.60 (-0.90%)
Prev Close
HK$66.70
Open
HK$67.65
Day's High
HK$67.65
Day's Low
HK$65.60
Volume
318,500
Avg. Vol
539,845
52-wk High
HK$68.90
52-wk Low
HK$32.88

Latest Key Developments (Source: Significant Developments)

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says Zhuhai-based biotechnology unit received drug clinical trial approval for drug named Recombinant Human anti-RANKL Monoclonal Antibody Solution for Injection.  Full Article

Livzon Pharmaceutical Co Announces Change In Shareholding Structure Of Livzon MABPharm
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::CO & JOINCARE PHARMACEUTICAL INDUSTRY ENTERED FRAMEWORK AGREEMENT RELATING TO CAPITAL CONTRIBUTION TO LIVZON BIOLOGICS.‍ACQUISITION CONSIDERATION OF 100% OF EQUITY INTERESTS OF LIVZON MAB BY BIOLOGICS TO BE RMB600 MILLION​.  Full Article

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says its unit received drug clinical trial approval for Recombinant Humanized anti-PD-1 Monoclonal Antibody for Injection .  Full Article

Livzon Pharmaceutical's net profits up in Q3, Jan-Sept
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>1513.HK:Says Q3 net profit up 1,719.2 percent y/y at 3.7 billion yuan ($556.85 million), 9-month net profit up 590.7 percent y/y at 4.2 billion yuan.  Full Article

Livzon Pharmaceutical sees FY net profit attributable between RMB4.32 bln - RMB4.48 bln
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::Sees FY net profit attributable between RMB4.32 billion - RMB4.48 billion.  Full Article

Livzon Pharmaceutical Group units receive approval for drug clinical trials
Monday, 18 Sep 2017 

Sept 18 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:* Says its units received drug clinical trials approval for drug, Triptorelin Acetate Microspheres for Injection.  Full Article

Livzon Pharma sees net profit up 20-30 pct in 2016
Friday, 13 Jan 2017 

Livzon Pharmaceutical Group Inc <000513.SZ><1513.HK> :Says it expects net profit to rise 20-30 percent y/y in 2016 at 747.2-809.4 million yuan ($117.36 million).  Full Article

Livzon Pharmaceutical Group raises 1.46 bln yuan via private placement
Monday, 19 Sep 2016 

Livzon Pharmaceutical Group Inc <000513.SZ>:Says it issued 29,098,203 shares at 50.1 yuan per share and raised 1.46 billion yuan in total via private placement.  Full Article

Livzon Pharma's H1 net profit up 20.0 pct
Friday, 19 Aug 2016 

Livzon Pharmaceutical Group Inc <000513.SZ><1513.HK> :Says H1 net profit up 20.0 percent y/y at 409.1 million yuan ($61.50 million).  Full Article

Livzon Pharmaceutical Group issues 350 mln yuan worth super short-term debentures
Monday, 15 Aug 2016 

Livzon Pharmaceutical Group <000513.SZ> Inc.: Says it issues first tranche of super short-term debentures for 2016 worth 350 million yuan, on Aug. 12, with a term of 270 days and coupon rate of 2.8 percent .Issue price at 100 yuan per face value of 100 yuan and maturity date May 9, 2017.  Full Article

BRIEF-Livzon Pharmaceutical Group Says Joincare To Sell 49 PCT Equity Interests In Livzon Mab

* PROPOSES TO ENTER AGREEMENT PURSUANT TO WHICH JOINCARE TO SELL 49% EQUITY INTERESTS IN LIVZON MAB FOR RMB294 MILLION Source text for Eikon: Further company coverage: